GB1440601A - Oxaprostaglandins - Google Patents

Oxaprostaglandins

Info

Publication number
GB1440601A
GB1440601A GB2584673A GB2584673A GB1440601A GB 1440601 A GB1440601 A GB 1440601A GB 2584673 A GB2584673 A GB 2584673A GB 2584673 A GB2584673 A GB 2584673A GB 1440601 A GB1440601 A GB 1440601A
Authority
GB
United Kingdom
Prior art keywords
formula
prostaglandins
compounds
oxo
single bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2584673A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/355,644 external-priority patent/US4094899A/en
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of GB1440601A publication Critical patent/GB1440601A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB2584673A 1972-06-02 1973-05-30 Oxaprostaglandins Expired GB1440601A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25921572A 1972-06-02 1972-06-02
US05/355,644 US4094899A (en) 1972-06-02 1973-04-30 Oxaprostaglandins

Publications (1)

Publication Number Publication Date
GB1440601A true GB1440601A (en) 1976-06-23

Family

ID=26947161

Family Applications (3)

Application Number Title Priority Date Filing Date
GB2584673A Expired GB1440601A (en) 1972-06-02 1973-05-30 Oxaprostaglandins
GB2306575A Expired GB1440602A (en) 1972-06-02 1973-05-30 Cyclopentane derivatives
GB2306775A Expired GB1440603A (en) 1972-06-02 1973-05-30 Alkyl phosphonates

Family Applications After (2)

Application Number Title Priority Date Filing Date
GB2306575A Expired GB1440602A (en) 1972-06-02 1973-05-30 Cyclopentane derivatives
GB2306775A Expired GB1440603A (en) 1972-06-02 1973-05-30 Alkyl phosphonates

Country Status (19)

Country Link
JP (3) JPS5314062B2 (xx)
AR (2) AR199300A1 (xx)
CA (1) CA1095034A (xx)
CH (3) CH590224A5 (xx)
DD (2) DD124594A5 (xx)
DE (2) DE2344838C3 (xx)
DK (1) DK143498C (xx)
ES (2) ES441003A1 (xx)
FI (1) FI55995C (xx)
GB (3) GB1440601A (xx)
IE (1) IE38568B1 (xx)
IL (2) IL42373A (xx)
IN (1) IN138739B (xx)
LU (1) LU67738A1 (xx)
NL (1) NL162902C (xx)
NO (1) NO145438C (xx)
PH (3) PH11300A (xx)
SE (4) SE415756B (xx)
YU (1) YU36497B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO143741C (no) * 1972-07-13 1981-04-08 Pfizer Analogifremgangsmaate for fremstilling av fysiologisk aktive prostaglandinforbindelser av e- og f-serien
WO2021040628A1 (en) 2019-08-28 2021-03-04 Igloocompany Pte. Ltd. System and method for controlling multiple locks

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538120A (en) * 1967-05-22 1970-11-03 Ciba Geigy Corp Cyclopentyl-alkanoic acids
ZA721159B (en) * 1971-03-22 1972-12-27 Ici Ltd Process for the separation of the c-15 epimers of 20-ethyl-9a,11alpha,15-trihydroxy-5-cis-13-trans-prostadienoic acid

Also Published As

Publication number Publication date
IL42373A (en) 1977-08-31
PH11300A (en) 1977-11-02
YU146973A (en) 1982-02-25
DE2344838B2 (de) 1981-04-09
IL42373A0 (en) 1973-07-30
SE7608222L (sv) 1976-07-19
JPS5728706B2 (xx) 1982-06-18
DE2344839A1 (de) 1974-02-28
ES441002A1 (es) 1977-03-01
DE2344838C3 (de) 1982-03-18
NO145438B (no) 1981-12-14
CA1095034A (en) 1981-02-03
SE418857B (sv) 1981-06-29
DE2344839B2 (de) 1976-06-24
PH12035A (en) 1978-10-16
CH589074A5 (xx) 1977-06-30
DE2344838A1 (de) 1973-12-20
FI55995B (fi) 1979-07-31
GB1440602A (en) 1976-06-23
DD109859A5 (xx) 1974-11-20
DD124594A5 (xx) 1977-03-02
NL162902C (nl) 1980-07-15
SE415756B (sv) 1980-10-27
NO740849L (no) 1973-12-04
AR199300A1 (es) 1974-08-23
JPS5314062B2 (xx) 1978-05-15
SE7608221L (sv) 1976-07-19
NO145438C (no) 1982-03-24
LU67738A1 (xx) 1973-12-10
IN138739B (xx) 1976-03-27
JPS4954349A (xx) 1974-05-27
AR203386A1 (es) 1975-09-08
FI55995C (fi) 1979-11-12
IL50311A (en) 1977-08-31
CH590224A5 (xx) 1977-07-29
YU36497B (en) 1984-02-29
IE38568B1 (en) 1978-04-12
AU5639373A (en) 1974-12-05
NL7307740A (xx) 1973-12-04
DK143498B (da) 1981-08-31
IE38568L (en) 1973-12-02
CH586716A5 (xx) 1977-04-15
NL162902B (nl) 1980-02-15
GB1440603A (en) 1976-06-23
JPS5239629A (en) 1977-03-28
PH11931A (en) 1978-09-13
ES441003A1 (es) 1977-03-16
JPS5231054A (en) 1977-03-09
DE2327813A1 (de) 1973-12-20
DK143498C (da) 1982-01-11
SE7608223L (sv) 1976-07-19

Similar Documents

Publication Publication Date Title
GB1515414A (en) 2 descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-omega-pentanorprostaglandins
GB1269657A (en) Prostaglandin analogues, their preparation and pharmaceutical compositions containing them
GB1456513A (en) Derivatives of cyclopentaneacetic acid
GB1373461A (en) Tetrazoyl derivatives of naturally occuring prostaglandins
SE7612262L (sv) Ketofosfonat-mellanprodukter och forfarande for framstellning derav
GB1450960A (en) Stabilization of prostaglandins
SE7504150L (sv) Prostaglandin kompositioner
GB1440601A (en) Oxaprostaglandins
GB1506824A (en) Prostaglandins
IE37909L (en) Prostaglandin analogues
GB1497218A (en) Thiaprostaglandins
GB1506817A (en) Prostaglandins
SE7704369L (sv) Mellanprodukter for framstellning av prostaglandiner
GB1396206A (en) Prostaglandins and the preparation thereof
GB1398291A (en) Prostaglandin analogues and production thereof
IE43815L (en) 11-deoxy-15-substituted-16, 17, 18, 19,¹20-pentanor-prostaglandins
GB1361863A (en) Piperazine derivatives their preparation and pharmaceutical compositions containing them
GB1430995A (en) 13-cis-prostaglandin derivatives and their preparation
GB1373878A (en) Prostaglandins and the preparation thereof
ES418575A1 (es) Un procedimiento para preparar un compuesto seleccionado delgrupo de antimeros y mezclas recenicas de los mismos.
GB1438093A (en) Prostaglandins and the manufacture thereof
GB1434620A (en) Prostaglandins and the preparation thereof
GB1362955A (en) Omega - homo - prostaglandin e1 heptyl ester and production thereof
GB1419221A (en) Calthrate prostaglandins and compositions containing same
GB1464205A (en) Prostaglandins

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee